Survivor Videos
958 articles
Let’s Win Receives Biden Cancer Initiative FIERCE Award
Let’s Win! Pancreatic Cancer Foundation is the inaugural winner of the Biden Cancer Initiative FIERCE Award for “Leadership through Exemplary and Awesome Purpose (LEAP).”
Let’s Win Inducted into the PR News Platinum Hall of Fame
Let’s Win has been inducted into the PR News Platinum Hall of Fame. Other inductees include the ALS Association’s ice bucket challenge.
New Crowdsourcing Platform Connects Pancreatic Cancer Patients to the Latest Studies
Dr. Allyson Ocean, a founder of Let’s Win, has a short video that explains how the website uses crowdsourcing of information for pancreatic cancer patients.
An Exemplary Life: The PR Lessons Anne Glauber Left Us
A tribute to the life, works, and pancreatic cancer treatment education mission of Anne Glauber, founder of Let’s Win, by Seth Arenstein.
Health Professional Radio: The Let’s Win Story
Neal Howard of Health Professional Radio interviews Anne Glauber about her pancreatic cancer diagnosis and how that led to founding Let’s Win.
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
Tweeting About Tumors and How Best to Provide Care
Dr. Michael Pishvaian launches #TumorBoardTuesday, a continuing medical education Twitter chat, to discuss patient treatments for GI cancers.
Tumor Subtypes Potentially Provide Clues About Prognosis and Treatment
Drs. Andrew Aguirre and David Ting are teasing out the differences between pancreatic cancer subtypes, to get treatments that work better.
Study Shows Fungi Boost Pancreatic Cancer Development and Growth
Drs. George Miller and Berk Aykut are leading research into the role of fungi in the growth and development of pancreatic cancer.
The Link Between Depression and Pancreatic Cancer
Drs. Annette Stanton and Michael Irwin outline the links between depression and pancreatic cancer, both as a symptom of the disease and post-diagnosis.
Targeting Cancer Metabolism
Researchers from Tyme Technologies are focusing on cancer cell metabolism, particularly tyrosine, as a way to kill cancer cells.
New Gene Inhibitor Drug for Patients with MTAP-Deleted Tumors
A new trial targets patients with advanced solid tumors, including pancreatic cancer, with an MTAP-deletion genetic mutation.
Accessing Daraxonrasib: A Quick Primer
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you.
Testing a Virus to Help Kill Pancreatic Tumor Cells
Researchers are testing whether cold virus can penetrate the tumor stroma and help kill pancreatic cancer cells.
Targeting Tumor Proteins Specific to Pancreatic Cancer Cells
A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.